期刊文献+

头孢吡肟的不同输注时间对化疗后粒细胞缺乏性发热患者临床疗效及结局的影响

Effect of different infusion time of cefepime on clinical efficacy and outcome of patients with febrile neutropenia after chemotherapy
原文传递
导出
摘要 目的:优化头孢吡肟的使用方法,探讨不同输注时间对头孢吡肟临床疗效及结局的影响。方法:将符合入组标准的化疗后中性粒细胞缺乏性发热(febrile neutropenia,FN)的患者,随机分为标准组和延长组,标准组:0.9%氯化钠溶液(NS)100 mL+头孢吡肟2 g,静脉滴注30 min,q8h;延长组:NS 100 mL+头孢吡肟2 g,静脉滴注3 h以上,q8h。观察2组患者24,48,72 h退热率,临床治疗成功率,住院时间,C反应蛋白(C-reactive protein,CRP)72 h变化值。结果:实际完成治疗患者共106例,其中标准组52例、延长组54例。标准组、延长组24 h退热率分别为27%、52%,差异有统计学意义(P=0.009);48 h退热率分别为56%、65%,72 h退热率分别为71%、81%,差异均无统计学意义,但延长组均有提高的趋势。2组患者中位退热时间分别为44,23 h,差异有统计学意义(χ^(2)=5.396,P=0.020)。2组患者临床治疗成功率分别为69%、83%,住院天数分别为16.5,13 d,差异均无统计学意义;72 h的CRP变化值分别为(58.36±38.20)、(77.84±47.36)mg·L^(-1),差异有统计学意义(P=0.022)。结论:延长头孢吡肟的单次输注时间,可能有助于提高FN患者的临床疗效,值得进一步研究。 OBJECTIVE To explore the effect of different infusion time of cefepime on clinical efficacy and outcome,and optimize the use of cefepime.METHODS Febrile neutropenia(FN)patients who met the inclusion criteria were randomly divided into standard group and extended group.Standard group:0.9%Soium Chloride Solution(NS)100 mL+cefepime 2 g,by intravenous infusion for 30 minutes,q8h;extended group:NS 100 mL+cefepime 2 g,by intravenous infusion for more than 3 h,q8h.The antipyretic rates at 24,48 and 72 h,clinical treatment success rate,length of stay and 72-h change value of C-reactive protein(CRP)were observed in the two groups.RESULTS A total of 106 patients actually completed the treatment,including 52 patients in the standard group and 54 patients in the extended group.The 24-h antipyretic rates of standard group and extended group were 27%and 52%,respectively,and the difference was statistically significant(P=0.009).The antipyretic rates of the two groups were 56%and 65%at 48 h,and 71%and 81%at 72 h,respectively,with no significant statistical difference.However,there was a trend of higher antipyretic rate in the extended group.The median antipyretic time of the two groups was 44 and 23 h,respectively,and the difference was statistically significant(χ^(2)=5.396,P=0.020).The clinical success rates and hospitalization days of the two groups were 69%and 83%,16.5 and 13 days,respectively,and there was no significant statistical difference.The 72-h change value of CRP of the two groups were(58.36±38.20)and(77.84±47.36)mg·L^(-1),respectively,and the difference was statistically significant(P=0.022).CONCLUSION Prolonged infusion time of cefepime may improve the clinical outcome of FN patients,which is worthy of clinical trials and further research.
作者 刘丹娜 苏田丽 吴通 陈露 赵晓丽 孙博 张二峰 王道协 孔天东 LIU Danna;SU Tianli;WU Tong;CHEN Lu;ZHAO Xiaoli;SUN Bo;ZHANG Erfeng;WANG Daoxie;KONG Tiandong(Department of Clinical Pharmacy,Cancer Hospital of Henan University/The Third People's Hospital of Zhengzhou,Henan Zhengzhou 450000,China;Department of Medical Oncology,Cancer Hospital of Henan University/The Third People's Hospital of Zhengzhou,Henan Zhengzhou 450000,China;Department of Intensive Care Unit,Cancer Hospital of Henan University/The Third People's Hospital of Zhengzhou,Henan Zhengzhou 450000,China)
出处 《中国医院药学杂志》 CAS 北大核心 2023年第11期1261-1265,共5页 Chinese Journal of Hospital Pharmacy
基金 河南省科技攻关计划(编号:202102310456) 河南省医学科技攻关联合共建计划(编号:2018020748)。
关键词 头孢吡肟 延长输注 中性粒细胞缺乏性发热 铜绿假单胞菌 cefepime extended infusion febrile neutropenia pseudomonas aeruginosa
  • 相关文献

参考文献4

二级参考文献34

共引文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部